Bryn Mawr Trust CO Pfizer Inc Transaction History

Bryn Mawr Trust CO

$5.48 Billion
Q3 2024

A detailed history of Bryn Mawr Trust CO transactions in Pfizer Inc stock. As of the latest transaction made, Bryn Mawr Trust CO holds 323,016 shares of PFE stock, worth $8.51 Million. This represents 0.17% of its overall portfolio holdings.

Number of Shares

323,016

Previous 158,984 103.18%

Holding current value

$8.51 Million

Previous $4.45 Million 110.16%

% of portfolio

0.17%

Previous 0.18%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 25, 2024	BUY	$27.7 - $31.39 $4.54 Million - $5.15 Million	164,032 Added 103.18%	323,016 $9.35 Million
Q2 2024 Aug 08, 2024	SELL	$25.26 - $29.6 $153,277 - $179,612	-6,068 Reduced 3.68%	158,984 $4.45 Million
Q1 2024 May 14, 2024	SELL	$25.89 - $29.73 $181,307 - $208,199	-7,003 Reduced 4.07%	165,052 $4.58 Million
Q3 2023 Nov 15, 2023	SELL	$32.09 - $37.51 $50,156 - $58,628	-1,563 Reduced 0.9%	172,055 $5.71 Million
Q2 2023 Aug 11, 2023	SELL	$36.12 - $41.79 $11,233 - $12,996	-311 Reduced 0.18%	173,618 $6.37 Million
Q1 2023 May 15, 2023	SELL	$39.39 - $51.28 $500,489 - $651,563	-12,706 Reduced 6.81%	173,929 $7.1 Million
Q4 2022 Feb 10, 2023	SELL	$41.75 - $54.5 $110,679 - $144,479	-2,651 Reduced 1.4%	186,635 $9.56 Million
Q3 2022 Nov 14, 2022	BUY	$43.76 - $53.42 $20,829 - $25,427	476 Added 0.25%	189,286 $8.28 Million
Q2 2022 Aug 11, 2022	SELL	$46.53 - $55.17 $332,224 - $393,913	-7,140 Reduced 3.64%	188,810 $9.9 Million
Q1 2022 May 16, 2022	SELL	$45.75 - $56.69 $525,027 - $650,574	-11,476 Reduced 5.53%	195,950 $10.1 Million
Q4 2021 Feb 10, 2022	SELL	$41.32 - $61.25 $125,984 - $186,751	-3,049 Reduced 1.45%	207,426 $12.2 Million
Q3 2021 Oct 26, 2021	SELL	$39.25 - $50.42 $23,196 - $29,798	-591 Reduced 0.28%	210,475 $9.05 Million
Q2 2021 Jul 29, 2021	BUY	$35.91 - $40.68 $59,933 - $67,894	1,669 Added 0.8%	211,066 $8.27 Million
Q1 2021 Apr 23, 2021	SELL	$33.49 - $37.77 $110,684 - $124,829	-3,305 Reduced 1.55%	209,397 $7.59 Million
Q4 2020 Feb 11, 2021	BUY	$33.47 - $42.56 $144,155 - $183,305	4,307 Added 2.07%	212,702 $7.83 Million
Q3 2020 Nov 12, 2020	SELL	$31.75 - $37.25 $122,269 - $143,449	-3,851 Reduced 1.81%	208,395 $7.65 Million
Q2 2020 Aug 13, 2020	SELL	$30.12 - $36.54 $235,538 - $285,742	-7,820 Reduced 3.55%	212,246 $6.94 Million
Q1 2020 May 08, 2020	BUY	$27.03 - $38.62 $36,544 - $52,214	1,352 Added 0.62%	220,066 $7.18 Million
Q4 2019 Feb 11, 2020	SELL	$32.92 - $37.36 $31,636 - $35,902	-961 Reduced 0.44%	218,714 $8.57 Million
Q3 2019 Oct 24, 2019	SELL	$32.49 - $42.13 $23,490 - $30,459	-723 Reduced 0.33%	219,675 $7.89 Million
Q2 2019 Aug 15, 2019	SELL	$36.98 - $41.52 $804,832 - $903,641	-21,764 Reduced 8.99%	220,398 $9.55 Million
Q1 2019 May 15, 2019	SELL	$37.5 - $41.2 $78,712 - $86,478	-2,099 Reduced 0.86%	242,162 $10.3 Million
Q4 2018 Feb 15, 2019	SELL	$38.47 - $43.86 $106,600 - $121,536	-2,771 Reduced 1.12%	244,261 $10.7 Million
Q3 2018 Nov 15, 2018	SELL	$34.47 - $41.81 $4,722 - $5,727	-137 Reduced 0.06%	247,032 $10.9 Million
Q2 2018 Aug 14, 2018	SELL	$32.98 - $35.16 $174,793 - $186,347	-5,300 Reduced 2.1%	247,169 $8.97 Million
Q1 2018 May 15, 2018	SELL	$31.91 - $37.02 $271,203 - $314,632	-8,499 Reduced 3.26%	252,469 $8.96 Million
Q4 2017 Feb 15, 2018	SELL	$33.26 - $35.29 $537,248 - $570,039	-16,153 Reduced 5.83%	260,968 $9.45 Million
Q3 2017 Aug 28, 2019	SELL	$31.0 - $34.15 $167,400 - $184,410	-5,400 Reduced 1.91%	277,121 $9.89 Million
Q3 2017 Nov 14, 2017	BUY	$31.0 - $34.15 $8.76 Million - $9.65 Million	282,521	282,521 $10.1 Million

Others Institutions Holding PFE

# of Institutions

3,260

Shares Held

3.61B

Call Options Held

77.2M

Put Options Held

122M

View Full List

About PFIZER INC

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $148B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

More about PFE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Bryn Mawr Trust CO, based on Form 13F filings with the SEC.

News

Stay updated on Bryn Mawr Trust CO with notifications on news.

Account

Bryn Mawr Trust CO Pfizer Inc Transaction History